Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

JWH-193

Synthetic naphthoylindole, CB1 agonist (IC50 2.8 nM in binding, rat); in France it falls under the generic clause on indol-3-yl methanones (literal reading).

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₆H₂₆N₂O₂

CAS 133438-58-1

Family
Synthetic CB receptor agonistNew psychoactive substance
Molar mass
398.50 g/mol

Updated on

In plain terms

JWH-193 is a synthetic cannabinoid with no botanical link to hemp. In laboratory assays on rat brain membranes it binds very strongly to the CB1 receptor, the target of THC. No study in humans was found, no dose is known, and in France it falls under the narcotics list through a generic clause, on a literal reading of the text.

Receptors and activity

Target network

CB1AgonistIC50 = 3.6 nM · mouseinhibition of electrically evoked contractions of the mouse vas deferens (assay used to distinguish agonists from antagonists); binding: IC50 of 2.8 nM, [3H]WIN 55212-2 displacement, rat brain; values read in ChEMBL (document CHEMBL1128746)
  • Activates

The lower the cited value, the closer the target sits to JWH-193: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of JWH-193.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1AgonistIC50 = 3.6 nM · mouse74 out of 100

    Eissenstat et al., J Med Chem 1995 (values read in ChEMBL, document CHEMBL1128746) (new tab) · inhibition of electrically evoked contractions of the mouse vas deferens (assay used to distinguish agonists from antagonists); binding: IC50 of 2.8 nM, [3H]WIN 55212-2 displacement, rat brain; values read in ChEMBL (document CHEMBL1128746)

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

JWH-193 is a synthetic naphthoylindole of the aminoalkylindole family, whose structure combines an indole core, a ketone linked to a naphthalene methylated at position 4 and a morpholinoethyl chain on the indole nitrogen, like JWH-200. Aminoalkylindoles were described by Sanofi Winthrop (Eissenstat et al. 1995) as cannabinoid receptor ligands, the key elements being a naphthyl at position 3, a small substituent at position 2 and a morpholinoethyl at position 1; according to ChEMBL, JWH-193 inhibits [3H]WIN 55212-2 binding to rat brain CB1 with an IC50 of 2.8 nM and mouse vas deferens contractions with an IC50 of 3.6 nM. Huffman and Padgett (2005) recall that the aminoalkyl group of this series can be replaced by an alkyl chain without loss of affinity. Zangani et al. (2020) place JWH-193 in category 2a of their survey of synthetic cannabinoids. No efficacy data of its own at CB2, no pharmacokinetics, metabolism or toxicology was found for this compound, and no study in humans.

History

Source
An entirely synthetic compound with no natural occurrence. Zangani et al. (2020) place it in category 2a of their survey of synthetic cannabinoids: neither listed by the EUDA nor by the UNODC, but scheduled in at least one jurisdiction and/or with evidence of abuse in peer-reviewed papers, and discussed on psychonaut sites.

Origin

Laboratory synthesis

No biological pathway: JWH-193 is a synthetic compound of the naphthoylindole class, not described in any living organism.

Classification

Family, origin and source verification

Family

Synthetic CB receptor agonist › New psychoactive substance

Class

naphthoylindole

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

JWH-193 (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

IUPAC name
(4-methylnaphthalen-1-yl)-[1-(2-morpholin-4-ylethyl)indol-3-yl]methanone

Identifiers

Formula
C₂₆H₂₆N₂O₂
CAS
133438-58-1
InChIKey
ICKWPPYMDARCKJ-UHFFFAOYSA-N
SMILES
CC1=CC=C(C2=CC=CC=C12)C(=O)C3=CN(C4=CC=CC=C43)CCN5CCOCC5

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.